Clinical trial
Determation of Median Effective Dose of Propofol Combined With Different Dose of Esketamine Inhibiting Response to Laryngeal Mask Airway Insertion in Female Patients
NCT06370130 is registered in ClinicalTrials.gov with Aerospace Center Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determation of Median Effective Dose of Propofol Combined With Different Dose of Esketamine Inhibiting Response to Laryngeal Mask Airway Insertion in Female Patients
- Lead sponsor
- Aerospace Center Hospital
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 1, 2022
- Completion date
- March 10, 2023
- Enrollment
- 58 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anesthesia